Trials / Conditions / Acute Upper Respiratory Infection

Acute Upper Respiratory Infection

10 registered clinical trials studyying Acute Upper Respiratory Infection.

Status	Trial	Sponsor	Phase
Completed	Evaluating the Potential of Large Language Models for Respiratory Disease Consultations NCT06457269	North Sichuan Medical College	N/A
Unknown	Clinical Trial to Assess the Efficacy and Safety of MUCOLASE Tablet(Streptokinase • Streptodornase) NCT04252963	Hanmi Pharmaceutical Company Limited	Phase 4
Completed	Treatment of Influenza and ARVI in Children by Kagocel ® NCT04651491	Nearmedic Plus LLC	—
Unknown	A Post-marketing Research on Jinyebaidu Granule in Treating Patients With Acute Upper Respiratory Infection NCT02539277	China Academy of Chinese Medical Sciences	Phase 4
Completed	Treatment of Influenza in Routine Clinical Practice NCT02983019	Nearmedic Plus LLC	—
Completed	Phase IV Trial,The Efficacy and Safety Study of Fuganlin Oral Liquid in Children With Acute Upper Respiratory NCT02654158	Guangzhou Yipinhong Pharmaceutical CO.,LTD	—
Withdrawn	Comparison of Supportive Therapies for Symptom Relief From Pediatric Upper Respiratory Infections (URIs) NCT01814293	University of California, San Francisco	N/A
Completed	Phase 3 Study of Pelubiprofen & Loxoprofen in Patients With Upper Respiratory Tract Infection NCT01779271	Daewon Pharmaceutical Co., Ltd.	Phase 3
Unknown	Impact of Introduction of PHiD-CV for Nunavik Children, Quebec, Canada NCT01694329	CHU de Quebec-Universite Laval	—
Completed	The Efficacy and Safety Study of Fuganlin Oral Liquid in Children With Influenza (Acute Upper Respiratory Infe NCT02622659	Guangzhou Yipinhong Pharmaceutical CO.,LTD	Phase 4